10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None
|
|
- Wilfrid Chapman
- 5 years ago
- Views:
Transcription
1 MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH None 1
2 Objectives Why the need for change in the guidelines? What is the potential impact of these guidelines? Where do we go from here? Kannel et al. Ann Intern Med
3 Kannel et al. AJC
4 Kannel et al. American Journal of Cardiology The relationship between Cholesterol and CHD is Linear MrFIT JAMA
5 Distributions of cholesterol levels and age-adjusted CHD deaths. Psaty B M Circulation 2010;121:
6 The Benefit of Statin Therapy is Independent of Baseline LDL Cholesterol CVD, DM or HTN Source: HPS Collaborative Group. Lancet 2002;360:7-22 Can you go to low? Hsia et al. JACC
7 Statin Good - More Statin Better Statin Therapy in Hypertensive Individuals Reduced CHD Events Source: Sever PS et al. Lancet. 2003;361:
8 Statin Therapy in Individuals with Diabetes Reduced CHD Events LDL <160mg/dl Atorvastatin 10mg Stopped early CARDS Trial New Cholesterol Guidelines Overall Theme Statins should be used to reduce ASCVD risk in individuals most likely to benefit Absolute risk is better predictor of benefit than cholesterol Statin therapy should be allocated based on absolute risk 8
9 Objectives Why the need for change in the guidelines? What is the potential impact of these guidelines? Where do we go from here? The 4 Statin Groups Known Clinical CVD Type II Diabetes LDL-C >190mg/dl Individuals with a >7.5% 10-year CVD Risk 9
10 Implications US Adults (40-75) in millions Statin-Eligibility in the U.S. Total Population ATP III ACC/AHA Pencina et al, NEJM 2014 Statin Eligibility in ARIC ASCVD Diabetes LDL > 190 CVD > 7.5% All 4 groups Miedema et al JAMA-IM
11 Objectives Why the need for change in the guidelines? What is the potential impact of these guidelines? Where do we go from here? Coronary Artery Calcium Score Mammogram of the heart Quantifies the amount of plaque in the coronary arteries ~.8 millisievert of Radiation Cost $100 11
12 Plaque Burden Strongly Correlates with CHD Risk Detrano et al. NEJM 2007 Mortality by CAC and age Tota-Maharaj European Heart Journal
13 Mortality by CAC and Risk Factors CAC Distribution by age MESA 13
14 CAC and CVD Events-Intermediate FRS Yeboah et al. JAMA. 2012; 308(8): CAC and CVD Events ACC/AHA Risk Calculator Sensitivity ASCVD ASCVD + CAC ASCVD + hscrp ASCVD + FH ASCVD + ABI , P= , P= , P= , P= Specificity Yeboah et al. AHA
15 CAC distribution across Statin Eligibility Groups 100% 90% 80% CAC distribution 70% 60% 50% 40% 30% % 41 10% 0% Recommend Statins Consider Statins Statins not recommended CAC = 0 CAC CAC > 100 Nasir et al. JACC 2015 CAC distribution Across Spectrum of 10 Year Risk Score Among those >7.5% Risk Score 100% CAC = 0 CAC CAC > 100 CAC distribution 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% % % % 20% N=431 N=608 N=342 N=441 15
16 CHD Event Rate Per 1000 Person Among Non Diabetics with LDL mg/dl Across Spectrum of CAC Burden & Increasing 10 Year ASCVD Risk >7.5% Categories CAC=0 CAC CAC> % % % 20% N=431 N=608 N=342 N=441 Dotted line represent reference line for 10 year ASCVD risk estimate of 7.5% ASCVD Event Rate Per 1000 Person Among Non Diabetics with LDL mg/dl Across Spectrum of CAC Burden & Increasing 10 Year ASCVD Risk >7.5% Categories CAC=0 CAC CAC> % % % 20% N=431 N=608 N=342 N=441 Dotted line represent reference line for 10 year ASCVD risk estimate of 7.5% 16
17 MESA An Evidenced-based Heart Healthy Diet Michael Miedema, MD MPH October 7th,
18 Objectives The obesity epidemic why are we gaining weight? Dietary fat intake very evil, not so evil.. healthy? An evidence based heart healthy diet what does the science really support? Levels of Evidence Anecdotal Basic Science/surrogate outcomes Observational Studies Randomized Controlled Trials 36 18
19 Anecdotal Evidence 37 Levels of Evidence Anecdotal Basic Science/surrogate outcomes Observational Studies Randomized Controlled Trials 38 19
20 The obesity epidemic Objectives Dietary fat intake An evidence based heart healthy diet
21 21
22 22
23 Prevalence of Self-Reported Obesity Among U.S. Adults % <20% 20% <25% 25% <30% 30% <35% 35% What Changed? Physical Inactivity? Processed foods? Dietary Pattern? Effect of tobacco and alcohol use? Poor Sleep? More Food? 23
24 We are eating more Trends in food consumption: 24
25 The importance of the food environment Plate size Moving from a 12 inch to a 10 inch dinner plate leads people to serve and eat 22% less. Low fat labels lead people to eat 16 23% more total calories. The Nutritional Gatekeeper influences an estimated 72% of all of the food their family eats. Visual illusions People pour 28% more into a short wide glasses than tall ones. Bulk purchases 50% of the snack food bought in bulk (such as at a warehouse club store) is eaten within six days of purchase. 25
26 Lessons from soup Single bowl vs self refilling bowl 8.5 oz vs 14.7 oz No difference in estimated consumption No difference in satiety Take Home Point #1 Your food environment has a significant impact on what and how much you eat 52 26
27 Does obesity cause CHD? CHD mortality rates The obesity epidemic Objectives Dietary fat intake An evidence based heart healthy diet 27
28 Conventional Wisdom? Total Fat, Saturated Fat Serum Total and LDL Cholesterol Coronary Heart Disease Total Fat Intake and Heart Disease Seven Countries Study 28
29 Dietary Fats & LDL-Cholesterol =0.032* SFA Change in LDL-C (mmol/l) =-0.009* =-0.019* 0 1% 2% 3% 4% 5% percentage of calories vs. carbohydrate MUFA PUFA Based on Mensink & Katan Figure from Micha & Mozaffarian, Lipids 2010 Dietary Fats & HDL Cholesterol 0.05 SFA HDL-C, mmol/l MUFA PUFA % 2% 3% 4% 5% percentage of calories vs. carbohydrate Based on a meta-analysis of 13 RCTs. Mozaffarian & Clarke, EJCN
30 Dietary Fats & Total Cholesterol Total:HDL-C Ratio SFA MUFA PUFA 0 1% 2% 3% 4% 5% percentage of calories vs. carbohydrate Based on a meta-analysis of 13 RCTs. Mozaffarian & Clarke, EJCN 2009 Total Fat and CHD Prospective Cohorts RR I II III IV V 28.3% 32.6% 35.6% 38.7% 44.0% Quintiles of Total Fat Consumption 77,878 women in the Nurses Health Study, , Oh et al, AJE
31 Food Sources: Red Meat Unprocessed Red Meat RR = 1.00 (0.81, 1.23) Processed Meats RR = 1.42 (1.07, 1.89) Micha et al., Circulation 2010 Food Sources: Milk/Dairy Multivariable adjusted relative risk comparing the highest to the lowest intake Mozaffarian D. Nutrition and Cardiovascular Disease. Chapter 48. Braunwald's Heart Disease; A Textbook of Cardiovascular Medicine, 9th Edition
32 If saturated fat goes out, what goes in? Change in CHD Risk for Each 5% Energy SFA PUFA * SFA Carb * Total of 344,696 individuals with 5,249 CHD events. *p<0.05 Jakobsen et al, AJCN 2009 If Saturated goes out, what goes in? SFA Low Glycemic Index Carb SFA Med Glycemic Index Carb Change in CHD Risk for Each 5% Energy SFA High Glycemic Index Carb * Risk of CHD among 53,644 adults followed for 12 years. *p<0.05 Jakobsen et al, AJCN
33 Take Home Point #2 Dietary fat intake does not appear to be as harmful as we once thought And maybe healthy? The obesity epidemic Objectives Dietary fat intake An evidence based heart healthy diet 33
34 Saturated Fat and Heart Disease No Significant Effect HR = 0.97 (95% CI = 0.90, 1.06) Women s Health Initiative RCT 48,835 US women, randomized to low fat, low saturated fat diet vs. control. Howard et al, JAMA
35 In Healthy Fat = Heart Attacks and Strokes 35
36 36
37 37
38 Can I just wait until I m 50 at then eat Healthy? Fruits and Vegetables during young adulthood and future plaque build up Odds Ratio Q1 (Reference) Q2 Q3 Miedema et al. Fruits and Vegetable and CAC CARDIA. ACC
39 Chocolate and CHD Alcohol and Cardiovascular Disease Matsumoto, Miedema, et al. Alcohol and Cardiovascular Disease. Journal of Prevention and Cardiopulmonary Rehab. In Press. 39
40 What Counts as a drink? Alcohol and Risk of CHD 40
41 Pattern of Use and CHD Pooled Analysis of Studies of Cardiac Death Relative Risk of Cardiac Death Total risk reduction = 36% (95% CI= 20 to 50%; p<0.001) mg/day EPA+DHA Intake (mg/d) (~ 2 g/week) Mozaffarian & Rimm. JAMA
42 Fish Oil No benefit to supplementation 42
43 Multivitamins No benefit 43
44 A heart healthy diet Mozaffarian & Ludwig, JAMA 2010 Special Thanks Dary Mozaffarian Mike Gaziano Luc Djousse The MHIF 44
45 45
Cardiac patient quality of life. How to eat adequately?
Cardiac patient quality of life How to eat adequately? François Paillard CV Prevention Center CHU Rennes JESFC, Paris, 17/01/2013 Mrs. L. 55 yrs, Coronary artery disease, normal weight, mild hypertension
More informationPattern of lipid biomarkers and risk of cardiovascular disease
Pattern of lipid biomarkers and risk of cardiovascular disease Robert Clarke Clinical Trial Service Unit University of Oxford 9 January 2017 Biomarkers for dietary fats Blood lipids (LDL, HDL, triglycerides,
More informationDyslipidemia in the light of Current Guidelines - Do we change our Practice?
Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease
More informationLow carbohydrate diets- do they have a place?
Low carbohydrate diets- do they have a place? Grant Schofield Professor of Public Health AUT University, Auckland NZ @grantsnz www.facebook.com/profgrant www.profgrant.com Atherogenic dyslipidemia is [primarily]
More informationHealthy Fats & Fatty Acids Current Dietary Recommendations and Popular Opinions
Healthy Fats & Fatty Acids Current Dietary Recommendations and Popular Opinions Presentation 1 of 2 Penny M. Kris-Etherton PhD RD FAHA FNLA FASN CLS Department of Nutritional Sciences Penn State University
More informationLipid Management 2013 Statin Benefit Groups
Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date
More information2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary
2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth
More informationNo relevant financial relationships
MANAGEMENT OF LIPID DISORDERS Balancing Benefits and harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial relationships baron@medicine.ucsf.edu
More informationModifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health
Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Robert Clarke Clinical Trial Service Unit University of Oxford 28 th May
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationDisclosure. No relevant financial relationships. Placebo-Controlled Statin Trials
MANAGEMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR RISK IN WOMEN: Balancing Benefits and Harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial
More informationGoing Coconut over Saturated Fat? Why So Much Confusion? Part 1 Interpreting Conflicting Research
Going Coconut over Saturated Fat? Why So Much Confusion? Part 1 Interpreting Conflicting Research Disclosures Alice H Lichtenstein Board Member/Advisory Panel Food and Nutrition Board, National Academies
More informationNew Paradigms in Predicting CVD Risk
New Paradigms in Predicting CVD Risk Imaging as an Integrator of Lifetime Risk Exposure Michael J. Blaha MD MPH Presented by: Michael J. Blaha September 24, 2014 1 Talk Outline Risk factors vs. Disease
More informationSaturated fat- how long can you go/how low should you go?
Saturated fat- how long can you go/how low should you go? Peter Clifton Baker IDI Heart and Diabetes Institute Page 1: Baker IDI Page 2: Baker IDI Page 3: Baker IDI FIGURE 1. Predicted changes ({Delta})
More informationDisclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2014 AAHP Fall Seminar Sherry Myatt, PharmD, BCPS Assistant Director of Pharmacy for
More informationNo relevant financial relationships
MANAGEMENT OF LIPID DISORDERS: WHERE DO WE STAND WITH THE NEW PRACTICE GUIDELINES? Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant financial relationships
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationDietary Reference Values: a Tool for Public Health
HOGE GEZONDHEISRAAD Dietary Reference Values: a Tool for Public Health CONSEIL SUPERIEUR DE LA SANTE Belgian Dietary Reference Values for Energy and Macronutrients: FATS G. De Backer Brussels, February
More informationChapter 18. Diet and Health
Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in
More informationLipids. PBHL 211 Darine Hachem, MS, LD
Lipids PBHL 211 Darine Hachem, MS, LD Outline Functions of lipids in our body Types of lipids Sources of lipids Recommendation of fat intake Fat association with heart diseases Provide energy (9Kcal/g
More informationHeart Disease Genesis
Heart Disease Genesis The Ultimate Lecture on CAD origins Petr Polasek MD FRCPC FACC Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationDiet and Non-Communicable Diseases (NCDs): latest evidence
Diet and Non-Communicable Diseases (NCDs): latest evidence Fumiaki Imamura, MS, PhD fumiaki.imamura@mrc-epid.cam.ac.uk 23 Nov 2016, London publications in our field N journals=436 N publications: 90000
More informationPrevention of Heart Disease: The New Guidelines
Prevention of Heart Disease: The New Guidelines Nisha I. Parikh MD MPH Assistant Professor of Medicine Division of Cardiology Department of Medicine University of California San Francisco May 18 th 2015
More informationImaging-Guided Statin Allocation: Seeing Is Believing
Imaging-Guided Statin Allocation: Seeing Is Believing The New Paradigm in Personalized Risk Assessment & Medication Prescribing Presented by: Michael J. Blaha May 15, 2014 1 General Principles of Talk
More informationShort and Long Term Prognosis after Coronary Artery Calcium Scoring
Short and Long Term Prognosis after Coronary Artery Calcium Scoring In Pre-Elderly and Elderly Patients Michael J. Blaha MD MPH Presented by: Michael J. Blaha July 24, 2017 1 Talk Outline 1. Coronary artery
More information3/25/2013. Healthy Aging: Approaches to Reduce Chronic Disease Risk. Overview. Chronic disease risk and older adults
Healthy Aging: Approaches to Reduce Chronic Disease Risk Alice H. Lichtenstein, D.Sc. Gershoff Professor of Nutrition Science and Policy Tufts University Overview Chronic disease risk and older adults
More informationCardiovascular risk potential of dietary saturated fats: an update and some implications
Cardiovascular risk potential of dietary saturated fats: an update and some implications Gerard Hornstra, PhD Med" Prof. Em. of Experimental Nutrition" Maastricht University" The Netherlands" Cardiovascular
More informationDisclosures. Prevention of Heart Disease: The New Guidelines. Summary of Talk. Four guidelines. No relevant disclosures.
Disclosures Prevention of Heart Disease: The New Guidelines No relevant disclosures Nisha I. Parikh MD MPH Assistant Professor of Medicine Division of Cardiology Department of Medicine University of California
More informationDiabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center
Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??
More informationWHICH DIET FOR THE PREVENTION OF CARDIOVASCULAR DISEASE MEAT OR VEGETARISM
WHICH DIET FOR THE PREVENTION OF CARDIOVASCULAR DISEASE MEAT OR VEGETARISM QUELLE ALIMENTATION POUR PRÉVENIR LES MALADIES CARDIOVASCULAIRES VIANDE OU VÉGÉTARISME Dr Jean-Michel LECERF Service de Nutrition
More informationCan foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw. Main categories of fats
Can foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw UNIVERSITY OF CAMBRIDGE Hong Kong July 6 213 Yerushalmy J Hilleboe HE NY State J Med 1957 Coronary heart disease
More information9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?
Primary Prevention of Heart Disease: What works? What doesn t? Samia Mora, MD, MHS Associate Professor, Harvard Medical School Associate Physician, Brigham and Women s Hospital October 2, 2015 Financial
More informationDairy matrix effects on T2 diabetes and cardiometabolic health?
Department of Nutrition, Exercise and Sports Dairy matrix effects on T2 diabetes and cardiometabolic health? Arne Astrup Head of department, professor, MD, DMSc. Department of Nutrition, Exercise and Sports
More informationSubclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD
Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.
More informationCT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong
CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong Promises, Pitfalls and Hard Truths of Coronary Calcium Scanning Selwyn Wong Ascot and Middlemore Hospitals Coronary Calcium Scoring
More informationControversies in Preventative Cardiology
Controversies in Preventative Cardiology Francisco Lopez-Jimenez, M.D., M.Sc, FACC, FAHA Professor of Medicine, Mayo Medical School Chair, Division of Preventive Cardiology Co-Director, Artificial Intelligence
More informationYoung high risk patients the role of statins Dr. Mohamed Jeilan
Young high risk patients the role of statins Dr. Mohamed Jeilan KCS Congress: Impact through collaboration CONTACT: Tel. +254 735 833 803 Email: kcardiacs@gmail.com Web: www.kenyacardiacs.org Disclosures
More informationSanger Heart & Vascular Institute Symposium 2015
Sanger Heart & Vascular Institute Symposium 2015 Cardiovascular Update For Primary Care Physicians William E. Downey, MD FACC FSCAI Medical Director, Interventional Cardiology Sanger Heart & Vascular Institute
More informationThe Art of Cardiovascular Risk Assessment
The Art of Cardiovascular Risk Assessment Laurence S. Sperling, M.D., FACC, FACP,FAHA, FASPC Professor of Medicine (Cardiology) Professor of Global Health Director- Center for Heart Disease Prevention
More informationCase Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer
Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,
More informationNutrition and Heart Disease. by Rachel Kay, MS, RDN, CD Clinical Nutrition Specialist at Swedish Medical Center
Nutrition and Heart Disease by Rachel Kay, MS, RDN, CD Clinical Nutrition Specialist at Swedish Medical Center Objectives 1. Be able to identify recommended diet changes for patients with cardiovascular
More informationNutrition Counselling
Nutrition Counselling Frieda Dähler Augustiny, Nutritional Counsellor Preventive Cardiology & Sports Medicine University Clinic of Cardiology Optimal Diet for Prevention of Coronary Heart Disease Diet
More informationFatty acids and cardiovascular health: current evidence and next steps
Fatty acids and cardiovascular health: current evidence and next steps Emanuele Di Angelantonio, MD, PhD Department of Public Health and Primary Care NICE guidelines on fatty acids Eliminate the use of
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationPlacebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES
MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest
More informationWidespread concern about the role of SFA in heart disease: Is it justified?
Widespread concern about the role of SFA in heart disease: Is it justified? 1. What is the association of SFA intake and LDL-C? 2. Is LDL-C the best biomarker? 3. If SFA is reduced, does it matter what
More informationOf Cows and Men: Reviewing the Link Between Dairy Fat and Human Health
Of Cows and Men: Reviewing the Link Between Dairy Fat and Human Health The Times, They Are A Changing To keep in mind: what 100% of experts believe and recommend usually changes over time Thomas Kuhn Eduardo
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationNUTRITION IN THE AGE OF EVIDENCE D A N A H. M A N N I N G P H A R M. D., R. D., L D N
NUTRITION IN THE AGE OF EVIDENCE D A N A H. M A N N I N G P H A R M. D., R. D., L D N OBJECTIVES List controversial points from the current Dietary Guidelines for Americans (DGA). Recognize the policy
More informationLow-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies
Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society
More informationDiabetes and Heart Disease
Diabetes and Heart Disease Sarah Alexander, MD Assistant Professor of Medicine Division of Cardiology Rush University Medical Center 2/8/2017 Rush is a not-for-profit health care, education and research
More informationLDL and the Benefits of Statin Therapy
LDL and the Benefits of Statin Therapy Allan Sniderman McGill University ACC/AHA did not recommend a target-based approach. Right? P 2899 The Expert Panel was unable to find any RCTs that evaluated titration
More informationThe health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences
The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences What should we be promoting? Define health benefits in terms
More informationAtherosclerotic Disease Risk Score
Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,
More informationConflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines
Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy
More informationFinancial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017
Coronary Artery Calcification Dharmendra A. Patel, MD MPH Director, Echocardiography Laboratory Associate Program Director Cardiovascular Disease Fellowship Program Erlanger Heart and Lung Institute UT
More informationLDL cholesterol and cardiovascular outcomes?
LDL cholesterol and cardiovascular outcomes? Prof Kausik Ray, BSc (hons), MBChB, FRCP, MD, MPhil (Cantab), FACC, FESC Professor of Cardiovascular Disease Prevention St Georges University of London Honorary
More informationPlacebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN
PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING THE DECREASE
More information4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for
+ Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics
More informationThe Mediterranean Diet: The Optimal Diet for Cardiovascular Health
The Mediterranean Diet: The Optimal Diet for Cardiovascular Health Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health Cardiovascular Disease Prevention International
More informationACC/AHA Guidelines Bulls-eyes and Misses
ACC/AHA Guidelines Bulls-eyes and Misses James Trippi, MD, FACC Diplomate American Board of Clinical Lipidology Complex Cholesterol Center of St. Vincent Health Indianapolis, IN October 18, 2014 Level
More informationDisclosure. No relevant financial relationships. Placebo-Controlled Statin Trials
PREVENTING CARDIOVASCULAR DISEASE IN WOMEN: Current Guidelines for Hypertension, Lipids and Aspirin Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial
More informationLipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice
Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice Vera Bittner, MD, MSPH Professor of Medicine Section Head, Preventive Cardiology Medical Director, Cardiac Rehabilitation
More informationCurrent Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD
Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center
More informationSession 21: Heart Health
Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk
More informationOverview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures
The Mediterranean Diet: The Optimal Diet for Cardiovascular Health No conflicts of interest or disclosures Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health
More informationWhat have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline?
What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline? Salim S. Virani, MD, PhD, FACC, FAHA Associate Professor, Section of Cardiovascular Research Baylor
More informationDisclosures No relationships (not even to an employer) No off-label uses. Cholesterol Lowering Guidelines: What now?
Disclosures No relationships (not even to an employer) No off-label uses Cholesterol Lowering Guidelines: What now?, FACP 1 2 65-year-old white woman Total cholesterol 175mg/dL HDL 54 mg/dl LDL 96 mg/dl
More informationCardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification
Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical Center, Torrance, CA
More informationThe Clinical Unmet need in the patient with Diabetes and ACS
The Clinical Unmet need in the patient with Diabetes and ACS Professor Kausik Ray (UK) BSc(hons), MBChB, MD, MPhil, FRCP (lon), FRCP (ed), FACC, FESC, FAHA Diabetes is a global public health challenge
More informationEvidence-based priority setting for dietary policies. Ashkan Afshin, MD MPH MSc ScD November 17, 2016 Acting Assistant Professor of Global Health
Evidence-based priority setting for dietary policies Ashkan Afshin, MD MPH MSc ScD November 17, 2016 Acting Assistant Professor of Global Health 1. Defining optimal nutrition Agenda Setting Policy Formulation
More informationEPOA. Latest Insights on Palm Oil & Health. European Industry Meeting on Palm Oil Nicolette Drieduite I EPOA Project team member I Cargill 2 June 2015
EPOA Latest Insights on Palm Oil & Health European Industry Meeting on Palm Oil Nicolette Drieduite I EPOA Project team member I Cargill 2 June 2015 Summary 1. In the nineties palm oil s success was related
More information2013 Lipid Guidelines Practical Approach. Edward Goldenberg, MD FACC,FACP, FNLA Medical Director of Cardiovascular Prevention CCHS
2013 Lipid Guidelines Practical Approach Edward Goldenberg, MD FACC,FACP, FNLA Medical Director of Cardiovascular Prevention CCHS EVIDENCE BASED MEDICINE Case #1 - LB 42 yo Asian/American female who was
More informationCase Study #4: Hypertension and Cardiovascular Disease
Helen Jang Tara Hooley John K Rhee Case Study #4: Hypertension and Cardiovascular Disease 7. What risk factors does Mrs. Sanders currently have? The risk factors that Mrs. Sanders has are high blood pressure
More informationFoodGate: The break-in, cover-up, and aftermath. Robert H. Lustig, M.D., M.S.L. Cristin Kearns, D.D.S., M.B.A. Laura Schmidt, Ph.D., M.P.H., L.C.S.W.
FoodGate: The break-in, cover-up, and aftermath Robert H. Lustig, M.D., M.S.L. Cristin Kearns, D.D.S., M.B.A. Laura Schmidt, Ph.D., M.P.H., L.C.S.W. Osher Mini Med School for the Public, Mar 6, 2018 Decrease
More informationCLINICAL OUTCOME Vs SURROGATE MARKER
CLINICAL OUTCOME Vs SURROGATE MARKER Statin Real Experience Dr. Mostafa Sherif Senior Medical Manager Pfizer Egypt & Sudan Objective Difference between Clinical outcome and surrogate marker Proper Clinical
More informationNo conflicts of interest or disclosures
Egg and Dairy Consumption: Impact on CVD Risk No conflicts of interest or disclosures Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health Cardiovascular Disease
More informationControlling Cholesterol and Diet Modifications
Reducing your Risk of Heart Disease Webinar Series Controlling Cholesterol and Diet Modifications Created with an educational grant from: About Mended Hearts Mended Hearts mission is: To inspire hope and
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationNew ACC/AHA Guidelines on Lipids: Are PCSK9 Inhibitors Poised for a Breakthrough?
New ACC/AHA Guidelines on Lipids: Are PCSK9 Inhibitors Poised for a Breakthrough? Sidney C. Smith, Jr. MD, FACC, FAHA Professor of Medicine/Cardiology University of North Carolina at Chapel Hill Immediate
More informationGlobal Burden of Disease Attributable to Sugar Sweetened Beverages
Global Burden of Disease Attributable to Sugar Sweetened Beverages Dariush Mozaffarian, MD DrPH Dean, Friedman School of Nutrition Science & Policy Press Conference Mexico City, Mexico November 11, 2014
More informationQuestions 4/8/2016. Cholesterol overview. Cholesterol biological functions Component of biological membranes. Cholesterol chemistry
How much cholesterol can be part of a healthful diet? Dietary cholesterol: The good, the bad, and the egg? Are there specific foods that should be limited because of their cholesterol content? Sonia Vega-López,
More informationRole of Dietary Fats and Cardiovascular Risk
Role of Dietary Fats and Cardiovascular Risk Julie Lovegrove Hugh Sinclair Unit of Human Nutrition & Institute for Cardiovascular and Metabolic Research University of Reading, UK Alpro Student Symposium
More information1/14/2013 Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of h
Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of hyperlipidemia. Identify risk factors that lead to the development
More informationTreating Lipids for Prevention of CAD in Women: Matching Therapy to Risk
TREATING LIPIDS FOR PREVENTION OF CAD IN WOMEN: MATCHING THERAPY TO RISK Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest
More informationSupplementary Online Content
Supplementary Online Content Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in cardiology practices
More informationCase Presentation. Moderator: Sharon Liu, DO Associate Internal Medicine Chief Austin Regional Clinic Austin, Texas
Case Presentation Moderator: Sharon Liu, DO Associate Internal Medicine Chief Austin Regional Clinic Austin, Texas Izzy (2006) 51 y/o Hispanic woman with a history of diabetes and obesity. Her diabetes
More information2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD
2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD How do you interpret my blood test results? What are our targets for these tests? Before the ACC/AHA Lipid Guidelines A1c:
More informationDietary Cholesterol in Cold Water Prawns: Implications for Cardiovascular Disease Risk
Dietary Cholesterol in Cold Water Prawns: Implications for Cardiovascular Disease Risk Professor Bruce Griffin Department of Nutritional Sciences Faculty of Health & Medical Sciences Coronary Heart Disease
More informationSupplemental table 1. Dietary sources of protein among 2441 men from the Kuopio Ischaemic Heart Disease Risk Factor Study MEAT DAIRY OTHER ANIMAL
ONLINE DATA SUPPLEMENT 1 SUPPLEMENTAL MATERIAL Pork Bacon Turkey Kidney Cream Cottage cheese Mutton and lamb Game (elk, reindeer) Supplemental table 1. Dietary sources of protein among 2441 men from the
More informationSugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA
Sugar-Loaded Beverages and the Impact on Cardiovascular Health Christina M. Shay, PhD, MA 1 Presenter Disclosure Information Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular
More informationSaturated Fats: What is the Link to Cardiovascular Disease?
Saturated Fats: What is the Link to Cardiovascular Disease? Benoît Lamarche, PhD Chair of Nutrition School of Nutrition INAF, Université Laval Québec, Canada CNS 2015 Winnipeg Disclosures Funding (last
More informationPlacebo-Controlled Statin Trials Prevention Of CVD in Women"
MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest
More informationHEART HEALTH AND HEALTHY EATING HABITS
HEART HEALTH AND HEALTHY EATING HABITS ELIZABETH PASH PENNIMAN RD,LD CLINICAL DIETITIAN Professional Member American Heart Association; Council on Nutrition, Physical Activity and Metabolism PURPOSE: Recognize
More information1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)
I. TEST YOUR KNOWLEDGE OF CHOLESTEROL Choose the correct answer. 1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) 2. Only
More informationUNIVERSITY OF CAMBRIDGE. Fatty acids and heart disease. Kay-Tee Khaw
UNIVERSITY OF CAMBRIDGE Fatty acids and heart disease Kay-Tee Khaw Bristol 3 October 2013 Yerushalmy J Hilleboe HE NY State J Med 1957 Coronary heart disease death rates in relation to blood cholesterol
More informationKathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School
Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review
More informationGiving Good Dietary Advice to Cardiovascular Patients
Giving Good Dietary Advice to Cardiovascular Patients Carmine D Amico, D.O. Learning objectives Introduction Basic principles Grocery shopping Cooking Eating out Snacking Staying active Summary Overview
More informationUpdate on Cholesterol Management: The 2013 ACC/AHA Guidelines
Update on Cholesterol Management: The 2013 ACC/AHA Guidelines Ola Akinboboye MD MPH MBA Medical Director, Queens Heart institute Rosedale. Associate Professor of Clinical Medicine, Weill Medical College
More informationNEW CLINICAL GUIDELINES FOR THE MANAGEMENT OF OBESITY AND METABOLIC SYNDROME
NEW CLINICAL GUIDELINES FOR THE MANAGEMENT OF OBESITY AND METABOLIC SYNDROME Alexander Frame, Richard Mathias School of Population and Public Health Obesity Pandemic (WHO) Developed Nations Developing
More information